Accordingly, while CXCL16+ tumor cells may trap T cells in the tumor mass, a tumor border composed by CXCL16+ glyCAF may, on the contrary, block T-cell migration and sequester the T cells in the tumor periphery. Here, CXCL16 is linked to neoplasm.